Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$3.54 - $4.64 $58,056 - $76,096
-16,400 Reduced 98.2%
300 $1,000
Q1 2019

May 15, 2019

BUY
$3.32 - $5.28 $33,200 - $52,800
10,000 Added 149.25%
16,700 $80,000
Q4 2018

Feb 14, 2019

SELL
$3.31 - $5.24 $41,044 - $64,976
-12,400 Reduced 64.92%
6,700 $23,000
Q3 2018

Nov 14, 2018

BUY
$3.48 - $4.6 $56,376 - $74,520
16,200 Added 558.62%
19,100 $86,000
Q2 2018

Aug 14, 2018

SELL
$3.85 - $5.15 $16,555 - $22,145
-4,300 Reduced 59.72%
2,900 $12,000
Q1 2018

May 15, 2018

SELL
$4.5 - $5.9 $15,300 - $20,060
-3,400 Reduced 32.08%
7,200 $36,000
Q4 2017

Feb 14, 2018

BUY
$3.95 - $5.3 $24,095 - $32,330
6,100 Added 135.56%
10,600 $46,000
Q3 2017

Nov 14, 2017

BUY
$3.9 - $4.6 $17,550 - $20,700
4,500
4,500 $18,000

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $205M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.